Chronic kidney disease (CKD) is associated with a mineral and bone disorder (CKD-MBD)
which starts early in the course of the disease and worsens with its progression. The main …

During the past few years, remarkable advances have been made in the understanding and
the management of parathyroid diseases in patients with chronic kidney disease (CKD). One …

Secondary hyperparathyroidism (SHP) is a common complication of chronic kidney disease
(CKD) that correlates with morbidity and mortality in uremic patients. It is characterized by …

In chronic kidney disease (CKD), several abnormalities in bone and mineral metabolism
develop in the majority of patients. The parathyroid plays a very important role in regulating …

Chronic Kidney disease (CKD) disturbs mineral homeostasis leading to mineral and bone
disorders (MBD). Serum calcium and phosphate (Pi) remain normal until the late stages of …

Among the chronic kidney disease–mineral bone disease (CKD-MBD) disorders,
osteoporosis and adynamic bone are highly prevalent, and they have been consistently …

Musculoskeletal problems remain among the main limitations of the quality of life of renal
failure patients, in particular of those treated with long-term maintenance dialysis. Renal …

Progression of secondary hyperparathyroidism involves deregulation of genes related to
DNA and RNA stability. Background Renal secondary hyperparathyroidism in its late stages …

Secondary hyperparathyroidism (SHPT) is an integral component of the chronic kidney
disease-mineral and bone disorder (CKD-MBD). Many factors have been associated with …

As kidney function declines, chronic kidney disease (CKD) becomes an increasingly
systemic disorder. Most patients with CKD eventually develop subclinical or clinical …